| Pyrimidine metabolism |
1.63 |
3.22e-1 |
40/56 (71.43%) |
RRM2;NT5E;DCK;...
|
| Sulfur relay system |
1.59 |
3.07e-1 |
5/8 (62.5%) |
TST;NFS1;MPST
|
| Cell cycle |
1.51 |
4.86e-1 |
110/124 (88.71%) |
PCNA;CDK1;WEE1;...
|
| Salivary secretion |
1.51 |
4.23e-1 |
76/93 (81.72%) |
PRKCA;ADCY1;LYZ;...
|
| Wnt signaling pathway |
1.49 |
4.14e-1 |
124/166 (74.7%) |
MMP7;PRKCA;LGR5;...
|
| Mucin type O-glycan biosynthesis |
1.48 |
3.94e-1 |
20/36 (55.56%) |
GALNT7;GALNT3;GALNT6;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
1.46 |
4.07e-1 |
49/53 (92.45%) |
PRKCA;KLK2;PLCB1;...
|
| Base excision repair |
1.44 |
4.19e-1 |
29/33 (87.88%) |
PCNA;POLD3;OGG1;...
|
| Oocyte meiosis |
1.43 |
4.06e-1 |
90/129 (69.77%) |
CDK1;ADCY1;PRKACB;...
|
| Pancreatic secretion |
1.38 |
5.41e-1 |
87/102 (85.29%) |
PRKCA;ADCY1;CPB1;...
|
| African trypanosomiasis |
1.38 |
5.12e-1 |
32/37 (86.49%) |
PRKCA;HBB;PLCB1;...
|
| Phosphatidylinositol signaling system |
1.38 |
4.76e-1 |
82/97 (84.54%) |
PRKCA;INPP5A;PLCB1;...
|
| Purine metabolism |
1.37 |
4.71e-1 |
102/129 (79.07%) |
RRM2;NT5E;ADCY1;...
|
| Renin-angiotensin system |
1.37 |
4.49e-1 |
20/23 (86.96%) |
KLK2;CPA3;ENPEP;...
|
| Circadian entrainment |
1.32 |
5.77e-1 |
85/97 (87.63%) |
GRIA2;PRKCA;ADCY1;...
|
| Other types of O-glycan biosynthesis |
1.30 |
5.96e-1 |
29/47 (61.7%) |
GALNT7;GALNT3;GALNT6;...
|
| Carbohydrate digestion and absorption |
1.30 |
5.76e-1 |
37/47 (78.72%) |
PLCB1;SLC2A5;PIK3R1;...
|
| Nicotinate and nicotinamide metabolism |
1.30 |
5.52e-1 |
25/35 (71.43%) |
NT5E;SIRT1;AOX1;...
|
| Complement and coagulation cascades |
1.24 |
6.15e-1 |
76/85 (89.41%) |
SERPINA1;CFB;F12;...
|
| Dilated cardiomyopathy |
1.23 |
6.17e-1 |
86/96 (89.58%) |
ADCY1;DES;PLN;...
|
| Long-term potentiation |
1.23 |
5.95e-1 |
61/67 (91.04%) |
GRIA2;PRKCA;ADCY1;...
|
| Prostate cancer |
1.13 |
6.23e-1 |
93/97 (95.88%) |
PDGFC;KLK3;MMP9;...
|
| Retinol metabolism |
1.13 |
6.11e-1 |
41/68 (60.29%) |
ALDH1A3;AOX1;HSD17B6;...
|
| Riboflavin metabolism |
1.13 |
6.07e-1 |
7/8 (87.5%) |
ACP2;ACP5
|
| FoxO signaling pathway |
1.12 |
6.22e-1 |
118/131 (90.08%) |
IRS2;PLK2;PIK3R1;...
|
| Spinocerebellar ataxia |
1.11 |
6.22e-1 |
128/143 (89.51%) |
GRIA2;PRKCA;PLCB1;...
|
| Mitophagy |
1.11 |
6.16e-1 |
56/68 (82.35%) |
CITED2;FIS1;TFEB;...
|
| Growth hormone synthesis, secretion and action |
1.11 |
6.13e-1 |
108/119 (90.76%) |
PRKCA;ADCY1;IRS2;...
|
| Cholinergic synapse |
1.10 |
6.18e-1 |
99/113 (87.61%) |
PRKCA;ADCY1;PLCB1;...
|
| Nicotine addiction |
1.10 |
6.17e-1 |
32/40 (80%) |
GRIA2
|
| Human papillomavirus infection |
-1.35 |
3.16e-1 |
284/331 (85.8%) |
FZD5;FZD9;COL4A1;...
|
| Yersinia infection |
-1.35 |
3.25e-1 |
120/137 (87.59%) |
WAS;PIK3CD;ARPC1A;...
|
| Thiamine metabolism |
-1.38 |
3.30e-1 |
12/15 (80%) |
ALPG;ACP1;ALPP;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.38 |
3.26e-1 |
49/77 (63.64%) |
UGT2B17;UGT2B15;ADH1B;...
|
| Glycine, serine and threonine metabolism |
-1.40 |
2.86e-1 |
31/40 (77.5%) |
GNMT;AOC2;BHMT;...
|
| Cytokine-cytokine receptor interaction |
-1.41 |
2.86e-1 |
246/295 (83.39%) |
CCR8;CCL27;CD40LG;...
|
| Viral myocarditis |
-1.41 |
2.94e-1 |
53/60 (88.33%) |
PRF1;LAMA2;EIF4G1;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.44 |
2.46e-1 |
172/193 (89.12%) |
RAC1;TRAF3;RELA;...
|
| Prion disease |
-1.44 |
2.43e-1 |
209/273 (76.56%) |
NDUFA2;PRNP;NDUFS2;...
|
| Proximal tubule bicarbonate reclamation |
-1.45 |
2.54e-1 |
21/23 (91.3%) |
GLS;ATP1A2;GLUD2;...
|
| Th17 cell differentiation |
-1.45 |
2.43e-1 |
95/107 (88.79%) |
IL2RG;TYK2;IL21R;...
|
| PPAR signaling pathway |
-1.46 |
2.41e-1 |
66/74 (89.19%) |
PLIN1;HMGCS2;ME1;...
|
| Synaptic vesicle cycle |
-1.47 |
2.41e-1 |
63/78 (80.77%) |
SLC1A7;SLC6A13;SLC6A11;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.47 |
2.50e-1 |
84/100 (84%) |
CCR8;CCL27;IL18R1;...
|
| Glycolysis / Gluconeogenesis |
-1.48 |
2.46e-1 |
56/67 (83.58%) |
HK2;ALDH3A1;ADH5;...
|
| Ether lipid metabolism |
-1.49 |
2.48e-1 |
32/49 (65.31%) |
PLA2G10;LPCAT4;PLPP2;...
|
| Ribosome |
-1.50 |
2.63e-1 |
113/158 (71.52%) |
MRPL15;MRPL3;RPS27L;...
|
| Pathogenic Escherichia coli infection |
-1.50 |
2.78e-1 |
152/197 (77.16%) |
ARPC1A;LPAR1;ARPC3;...
|
| Nitrogen metabolism |
-1.51 |
2.82e-1 |
16/17 (94.12%) |
GLUD2;CA7;CPS1;...
|
| Protein processing in endoplasmic reticulum |
-1.60 |
1.40e-1 |
127/171 (74.27%) |
SEC13;FBXO2;DDIT3;...
|
| Thyroid cancer |
-1.61 |
1.28e-1 |
36/37 (97.3%) |
CTNNB1;MAPK3;CCND1;...
|
| Parkinson disease |
-1.62 |
1.39e-1 |
176/249 (70.68%) |
NDUFA2;NDUFS2;GPR37;...
|
| Bacterial invasion of epithelial cells |
-1.63 |
1.48e-1 |
59/77 (76.62%) |
PIK3CD;ARPC1A;CTNNA3;...
|
| Oxidative phosphorylation |
-1.63 |
1.66e-1 |
93/133 (69.92%) |
NDUFA2;NDUFS2;ATP5PD;...
|
| Cell adhesion molecules |
-1.67 |
1.21e-1 |
118/148 (79.73%) |
MADCAM1;PDCD1LG2;ICOS;...
|
| Collecting duct acid secretion |
-1.69 |
1.29e-1 |
22/27 (81.48%) |
ATP6V1B1;ATP6V0E1;CLCNKB;...
|
| Spliceosome |
-1.69 |
1.55e-1 |
101/150 (67.33%) |
RBM8A;DHX38;RBM22;...
|
| Fatty acid elongation |
-1.71 |
1.66e-1 |
19/27 (70.37%) |
PPT1;ELOVL4;ELOVL5;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.78 |
1.01e-1 |
62/70 (88.57%) |
ATP6V1A;ATP6V0C;CCL5;...
|
| Protein export |
-1.79 |
2.02e-1 |
17/23 (73.91%) |
SEC61A1;SRP9;SRP14;...
|
